Awardee OrganizationAMERICAN ASSOCIATION FOR CANCER RESEARCH
Description
Abstract Text
Project Summary/Abstract
The Methods in Clinical Cancer Research Workshop is a week-long program designed to
educate and train early-career investigators in the best practices of clinical trial design, provide
access to experienced clinical investigators from different institutions with expertise across all
areas of clinical research, and develop and foster both peer-to-peer and mentoring relationships
to enhance career development beyond the dates of the Workshop. Students are selected using
a competitive application process that consists of a protocol concept, personal statement, and
support from an existing mentor. Those accepted to the Workshop will have access to dozens of
faculty members who, through the course of the Workshop, will help students develop concept
sheets into IRB-ready clinical trials, including informed consent documents, ready for
submission at their home institutions.
Students participate in pre- and post-tests to determine the effectiveness of the program, which
features a mix of didactic lectures, small group discussions, one-on-one mentoring sessions,
and daily protocol development group sessions. The protocol development group sessions are
made up of 3-4 faculty members and 8-10 students that work collaboratively as a group for the
week. This makes up the core of the Workshop as the groups meet daily to review progress
made each day and provide feedback and guidance for next steps in their individual trial
designs. Daily, progressive assignments are submitted each evening, with reviews and
comments from the faculty provided the following morning.
The Workshop is offered to early-career investigators in all oncology disciplines who are nearing
completion of their training or have recently begun their initial faculty positions. A review of the
literature, comments from Workshop attendees, and the number of similar programs being
developed in the U.S. and internationally shows that, despite advances in basic science and
new preclinical agent development, there is a serious shortage of clinical investigators who have
the pre-requisite knowledge to actually design and conduct effective clinical trials to match the
attributes of these new agents. With the ever-increasing pace of technology and its implications
in clinical trial design, the knowledge and number of tools that a clinical investigator needs to be
able to utilize effectively continue to grow at a rapid rate. The Workshop is designed to address
the needs today, while maintaining flexibility to implement changes to train early-career
investigators on how to conduct effective clinical trials in the future. The Workshop is organized
by the American Association for Cancer Research and the American Society of Clinical
Oncology and has provided training to over 1800 investigators since its’ inception in 1996.
The Workshop is evaluated through the use of pre- and post-tests given to the students; daily
and week-long evaluations completed onsite; a 1-year, 3-year, 5-year, and 10-year followup
survey each fall. The Workshop also contracted with an independent data-mining and analysis
firm in 2013-2014 to provide a long-term historical comparison of students and non-students
(applicants that were not accepted) that quantified their effectiveness pre- and post-Workshop in
the areas of successful clinical trials, publications, grants, and collaborations.
Public Health Relevance Statement
Project Narrative
The Workshop trains early-career investigators how to design and conduct cancer clinical trials
that produce definitive results. Its primary goal is to assure that new therapeutic and preventive
agents are tested in the clinic in as sound and as efficient a manner as possible. Training,
mentoring, and retaining clinical cancer trialists benefits public health by increasing the speed
and number of agents that can be tested and made available to prevent cancer and improve the
care and treatment of cancer patients.
NIH Spending Category
CancerPrevention
Project Terms
AccelerationAddressAmerican Association of Cancer ResearchAmerican Society of Clinical OncologyAreaBasic ScienceCancer PatientCareer ChoiceCaringClinicClinicalClinical InvestigatorClinical ResearchClinical TrialsClinical Trials DesignCollaborationsConduct Clinical TrialsConsent FormsContractsDataData ReportingDevelopmentDisciplineEducational workshopEffectivenessEnsureEthnic OriginEvaluationFacultyFeedbackFosteringFundingFutureGenderGeographyGoalsGrantHomeImmunologicsIndividualInstitutionInstitutional Review BoardsInternationalKnowledgeMalignant NeoplasmsMentorsMentorshipMethodologyMethodsNational Cancer InstituteNew AgentsOncologyParticipantPatient RecruitmentsPatient Self-ReportPatientsPhasePositioning AttributePreventionPreventiveProceduresProcessProgram EffectivenessProtocols documentationPublic HealthPublicationsPublished CommentResearch PersonnelReview LiteratureSiteSpeedStudent SelectionsStudentsSurveysTeaching MethodTechnologyTestingTrainingTranslational ResearchWorkanticancer researchcancer clinical trialcancer therapycareercareer developmentcareer networkingclinical practiceclinical trial readinessdata miningdesigneffectiveness evaluationevaluation/testingexperiencefallsflexibilityfollow-upimprovedlecturesmembernovel therapeuticspatient oriented researchpeerphase 2 designsphase II trialpre-clinicalpreventprogramsprotocol developmentrecruitsoundstudent participationsuccesstargeted treatmenttooltrial design
No Sub Projects information available for 3R25CA068647-23S1
Publications
Publications are associated with projects, but cannot be identified with any particular year of the project or fiscal year of funding. This is due to the continuous and cumulative nature of knowledge generation across the life of a project and the sometimes long and variable publishing timeline. Similarly, for multi-component projects, publications are associated with the parent core project and not with individual sub-projects.
No Publications available for 3R25CA068647-23S1
Patents
No Patents information available for 3R25CA068647-23S1
Outcomes
The Project Outcomes shown here are displayed verbatim as submitted by the Principal Investigator (PI) for this award. Any opinions, findings, and conclusions or recommendations expressed are those of the PI and do not necessarily reflect the views of the National Institutes of Health. NIH has not endorsed the content below.
No Outcomes available for 3R25CA068647-23S1
Clinical Studies
No Clinical Studies information available for 3R25CA068647-23S1
News and More
Related News Releases
No news release information available for 3R25CA068647-23S1
History
No Historical information available for 3R25CA068647-23S1
Similar Projects
No Similar Projects information available for 3R25CA068647-23S1